Caprock Group LLC Reduces Stock Position in Humana Inc. (NYSE:HUM)

Caprock Group LLC reduced its holdings in shares of Humana Inc. (NYSE:HUM) by 24.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,850 shares of the insurance provider’s stock after selling 586 shares during the period. Caprock Group LLC’s holdings in Humana were worth $471,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. FNY Investment Advisers LLC increased its holdings in Humana by 6,647.5% during the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock valued at $6,916,000 after buying an additional 26,856 shares during the last quarter. PDT Partners LLC increased its holdings in Humana by 190.0% during the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after buying an additional 2,660 shares during the last quarter. Secure Asset Management LLC purchased a new stake in Humana during the fourth quarter valued at approximately $244,000. Ontario Teachers Pension Plan Board increased its holdings in Humana by 6.5% during the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after buying an additional 71,910 shares during the last quarter. Finally, Swedbank AB increased its holdings in Humana by 3.0% during the third quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock valued at $33,567,000 after buying an additional 3,085 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

HUM has been the topic of several analyst reports. Piper Sandler lifted their price target on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. KeyCorp initiated coverage on shares of Humana in a report on Friday, October 11th. They set a “sector weight” rating on the stock. Truist Financial lifted their price target on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. Wells Fargo & Company lowered their price target on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. Finally, Sanford C. Bernstein raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price target on the stock in a report on Tuesday, October 8th. Nineteen research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $297.68.

Insider Buying and Selling

In related news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.29% of the stock is owned by corporate insiders.

Humana Price Performance

Shares of Humana stock opened at $295.68 on Wednesday. The stock has a 50 day moving average price of $275.13 and a 200-day moving average price of $300.37. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The stock has a market cap of $35.60 billion, a price-to-earnings ratio of 26.19, a price-to-earnings-growth ratio of 2.21 and a beta of 0.56. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.